CA-DIALPAD-INC.
17.6.2021 01:59:05 CEST | Business Wire | Press release
Dialpad Inc. , the industry leader in AI-powered communication and collaboration, today announced its platform integration with Microsoft Teams , a leading solution for team collaboration and engagement. Dialpad for Microsoft Teams is a cloud-native direct routing integration that seamlessly connects Dialpad’s enterprise-grade telephony features and award-winning Voice Intelligence (Vi™) capabilities into the Microsoft Teams native environment.
According to Microsoft’s Hybrid Work Trend Index , workers report that their productivity has either remained the same or increased over the past year. As work methods continue to evolve, Dialpad is at the forefront, creating better, smarter and more seamless communication experiences. With Dialpad direct routing at the heart of the integration, Microsoft Teams users have access to Dialpad’s global calling capabilities with PSTN connectivity in 49 countries in addition to sophisticated inbound and outbound calling features. Powered by automatic speech recognition, natural language processing and machine learning, Dialpad Vi provides Microsoft Teams users with real-time transcriptions, robust analytics, in-call coaching and intelligent conversation insights during every call.
“Today's technology and communications investments need to be in solutions that wholly integrate into how businesses work today, yet are flexible and scalable to evolve with them tomorrow,” said Craig Walker, Chief Executive Officer, Dialpad. “Today, more than 145 million people are using Microsoft Teams as their team collaboration tool, and nobody in the unified communications space does telephony services better than Dialpad. We’re excited to see the positive impact Dialpad direct routing will have on the calling experience for businesses using Microsoft Teams. With an open integration platform that natively extends and unifies business applications, Dialpad is delivering the best tools for teams to do their best work, both today and tomorrow.“
The coronavirus pandemic opened the business world’s eyes to new ways of working and ushered in the era of a hybrid work environment. Companies have implemented multiple tools to keep remote employees connected and engaged through video conferencing, messaging and chat tools, along with more traditional voice solutions. In addition to standard role responsibilities, employees face a new learning curve to integrate these tools into their workday. The management of multiple applications for a single, simple conversation can have detrimental effects on team productivity. Dialpad for Microsoft Teams centralizes and streamlines employee communications for more efficient, engaged, and ultimately, inclusive teams.
“The Dialpad integration with Microsoft Teams brings the best from both worlds — Microsoft Teams' collaboration and Dialpad's voice and real-time artificial intelligence capabilities,” said Ignacio Miranda, IT Vendor Manager, Gategroup. “An easy implementation and trouble-free user experience allows end-users to stay connected from anywhere, on any device, and enjoy a much better experience.”
From small and midsize businesses to large enterprises, organizations need a secure and reliable communications solution that enables seamless internal and external connections. Built for today’s modern hybrid workforce, Dialpad for Microsoft Teams provides a dynamic, flexible, highly scalable and reliable solution that is available on any device, at any time, anywhere in the world.
“Dialpad has focused on supporting highly distributed organizations and improving operational efficiency and productivity through its mobile-first, cloud-based unified communications and contact center solutions since its early days,” said Raul Castanon-Martinez, Senior Analyst, 451 Research, part of S&P Global Market Intelligence. “The integration with Microsoft Teams shows that the company continues to build and expand on this vision.”
See the Dialpad App Marketplace for more information on Dialpad for Microsoft Teams.
Additional Resources
- Check the latest blog for more details of Dialpad for Microsoft Teams.
- Learn why Dialpad is a Major Player in the IDC MarketScape: Worldwide UCaaS Service Providers for SMB and Enterprise 2021 Vendor Assessments
- Discover how Dialpad utilizes AI to unify UCaaS and CCaaS
About Dialpad
Dialpad is the leading cloud communications platform for AI-powered calling, conferencing and contact centers. Dialpad's proprietary, real-time Artificial Intelligence engine, Voice Intelligence (Vi™), helps businesses make smarter decisions by giving real-time insights on every call. Built on the Google Cloud Platform for unmatched security and reliability, Dialpad is easy to deploy, integrate and scale. Today, more than 70,000 of the world’s most innovative businesses use Dialpad and its seamless integrations with Google Workspace, Hubspot, Microsoft Office 365, Salesforce, Zendesk and others to allow every user to be more productive. Customers include T-Mobile, Twitter, WeWork, Uber, Stripe, Netflix, Motorola Solutions, Splunk and Domo. Dialpad is backed by the world’s leading investors including Amasia, Andreessen Horowitz, Felicis Ventures, GV, ICONIQ Capital, OMERS Growth Equity, Salesforce Ventures, Scale Ventures, Section 32, SoftBank Corp., T-Mobile Ventures and Work-Bench. Headquartered in the United States, Dialpad has offices in Australia/New Zealand, Brazil, Canada, India, Japan and the UK. Visit www.dialpad.com for more information and to request a demo.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210616006034/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom